Zomedica Corp Stock Ownership - Who owns Zomedica?

Insider buying vs selling

Have Zomedica Corp insiders been buying or selling?
Johnny D. PowersDirector2023-12-15100,000$0.17
Johnny D. PowersDirector2023-12-15100,000$0.17
Johnny D. PowersDirector2023-11-17100,000$0.17
Larry C. Heaton IiCEO2023-11-17100,000$0.17
Johnny D. PowersDirector2023-11-15150,000$0.17
Larry C. Heaton IiCEO2023-05-26100,000$0.19
Johnny D. PowersDirector2023-05-25100,000$0.19

1 of 1

ZOM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ZOM insiders and whales buy or sell their stock.

ZOM Shareholders

What type of owners hold Zomedica Corp stock?
Vanguard Group Inc4.99%48,903,589$6.36MInstitution
Gerald Solensky Jr.3.93%38,545,671$5.01MInsider
Jeffrey M. Rowe1.25%12,240,480$1.59MInsider
Family Gst Trust Rowe1.13%11,120,000$1.45MInsider
Blackrock Inc1.06%10,390,650$1.35MInstitution
Geode Capital Management LLC1.03%10,120,991$1.32MInstitution
State Street Corp0.34%3,321,681$431.82kInstitution
Proshare Advisors LLC0.26%2,573,819$334.60kInstitution
Brown Brothers Harriman Co0.25%2,466,532$320.65kInstitution
Johnny D. Powers0.20%1,950,000$253.50kInsider

1 of 3

ZOM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ZOM8.88%6.87%Net BuyingNet Buying
TKNO13.81%83.46%Net BuyingNet Buying
EBS45.65%54.35%Net Selling
FTLF0.86%99.14%Net BuyingNet Buying

Zomedica Stock Ownership FAQ

Who owns Zomedica?

Zomedica (NYSEMKT: ZOM) is owned by 8.88% institutional shareholders, 6.87% Zomedica insiders, and 84.25% retail investors. Gerald Solensky Jr. is the largest individual Zomedica shareholder, owning 38.55M shares representing 3.93% of the company. Gerald Solensky Jr.'s Zomedica shares are currently valued at $4.93M.

If you're new to stock investing, here's how to buy Zomedica stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.